Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Kapp AV"'
Autor:
Juric D, Dienstmann R, Cervantes A, Hidalgo M, Messersmith W, Blumenschein GR, Tabernero J, Roda D, Calles A, Jimeno A, Wang X, Bohórquez SS, Leddy C, Littman C, Kapp AV, Shames DS, Penuel E, Amler LC, Pirzkall A, Baselga J
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research
r-INCLIVA. Repositorio Institucional de Producción Científica de INCLIVA
instname
r-INCLIVA. Repositorio Institucional de Producción Científica de INCLIVA
instname
Purpose: The novel dual-action humanized IgG1 antibody MEHD7945A targeting HER3 and EGFR inhibits ligand-dependent HER dimer signaling. This phase I study evaluated the safety, pharmacokinetics, pharmacodynamics, and antitumor activity of MEHD7945A.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=RECOLECTA___::5a68d62c37b71f8ece68f99ab9a6939c
https://www.fundanet.incliva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=1516
https://www.fundanet.incliva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=1516
Publikováno v:
Annals of Allergy, Asthma & Immunology; Sep2011, Vol. 107 Issue 3, p273-280.e1, 1p
Autor:
Hill AG; Tasman Oncology Research, Southport, Australia. andrewgrahamhill@gmail.com., Findlay MP; Discipline of Oncology, University of Auckland, Auckland, New Zealand., Burge ME; Royal Brisbane and Women's Hospital, Herston, Australia; University of Queensland, Queensland, Australia., Jackson C; Department of Medicine, Dunedin School of Medicine, University of Otago, Dunedin, New Zealand., Alfonso PG; Gregorio Marañón Hospital, Madrid, Spain., Samuel L; Aberdeen Royal Infirmary, Aberdeen, United Kingdom., Ganju V; Peninsula Oncology Centre, Frankston, Australia., Karthaus M; Staedtisches Klinikum Muenchen GmbH-Klinikum Neuperlach, Munich, Germany., Amatu A; Niguarda Cancer Center, Grande Ospedale Metropolitano Niguarda, Milan, Italy., Jeffery M; Canterbury Regional Cancer and Haematology Service, Christchurch, New Zealand., Bartolomeo MD; Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Bridgewater J; University College London Cancer Institute, London, UK., Coveler AL; University of Washington, Seattle, Washington., Hidalgo M; Centro Integral Oncologico Clara Campal (CIOCC), Madrid, Spain., Kapp AV; Genentech, Inc., South San Francisco, California., Sufan RI; Genentech, Inc., South San Francisco, California., McCall BB; Genentech, Inc., South San Francisco, California., Hanley WD; Genentech, Inc., South San Francisco, California., Penuel EM; Genentech, Inc., South San Francisco, California., Pirzkall A; Genentech, Inc., South San Francisco, California., Tabernero J; Vall d'Hebron University Hospital and Institute of Oncology (VHIO), Universitat Autònoma de Barcelona, CIBERONC, Barcelona, Spain.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2018 May 15; Vol. 24 (10), pp. 2276-2284. Date of Electronic Publication: 2018 Mar 05.
Autor:
Kim SB; Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea. Electronic address: sbkim3@amc.seoul.kr., Dent R; Division of Medical Oncology, National Cancer Centre, Singapore, Singapore., Im SA; Department of Internal Medicine, Seoul National University Hospital, Cancer Research Institute, Seoul National University College of Medicine, Seoul, South Korea., Espié M; Breast Disease Center, Hospital Saint Louis, Paris, France., Blau S; Northwest Medical Specialties and Division of Oncology, University of Washington, Washington, WA, USA., Tan AR; Levine Cancer Institute, Carolinas HealthCare System, Charlotte, NC, USA., Isakoff SJ; Massachusetts General Hospital, Boston, MA, USA., Oliveira M; Medical Oncology Department, Vall d'Hebron University Hospital, Vall d'Hebron Institute of Oncology, Barcelona, Spain., Saura C; Medical Oncology Department, Vall d'Hebron University Hospital, Vall d'Hebron Institute of Oncology, Barcelona, Spain., Wongchenko MJ; Genentech Inc, South San Francisco, CA, USA., Kapp AV; Genentech Inc, South San Francisco, CA, USA., Chan WY; Genentech Inc, South San Francisco, CA, USA., Singel SM; Genentech Inc, South San Francisco, CA, USA., Maslyar DJ; Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea., Baselga J; Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Publikováno v:
The Lancet. Oncology [Lancet Oncol] 2017 Oct; Vol. 18 (10), pp. 1360-1372. Date of Electronic Publication: 2017 Aug 08.
Autor:
Lieu CH; Division of Medical Oncology, University of Colorado Health Sciences Center, Aurora, Colorado, USA Christopher.lieu@ucdenver.edu., Hidalgo M; START Madrid, Centro Integral Oncologico Clara Campal (CIOCC), Madrid, Spain., Berlin JD; Vanderbilt-Ingram Cancer Center, Nashville, Tennessee, USA., Ko AH; UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, California, USA., Cervantes A; Department of Medical Oncology, Biomedical Research Institute INCLIVA, CIBERONC, University of Valencia, Valencia, Spain., LoRusso P; Karmanos Cancer Center, Detroit, Michigan, USA., Gerber DE; Harold C. Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, Texas, USA., Eder JP; Yale Smilow Cancer Center, New Haven, Connecticut, USA., Eckhardt SG; Division of Medical Oncology, University of Colorado Health Sciences Center, Aurora, Colorado, USA., Kapp AV; Genentech, Inc., South San Francisco, California, USA., Tsuhako A; Genentech, Inc., South San Francisco, California, USA., McCall B; Genentech, Inc., South San Francisco, California, USA., Pirzkall A; Genentech, Inc., South San Francisco, California, USA., Uyei A; Genentech, Inc., South San Francisco, California, USA., Tabernero J; Vall d'Hebron University Hospital and Institute of Oncology, CIBERONC, Universitat Autònoma de Barcelona, Barcelona, Spain.
Publikováno v:
The oncologist [Oncologist] 2017 Sep; Vol. 22 (9), pp. 1024-e89. Date of Electronic Publication: 2017 Jun 07.
Autor:
Jimeno A; Division of Medical Oncology, University of Colorado School of Medicine, Aurora, Colorado., Machiels JP; King Albert II Institute, Medical Oncology Service, Saint-Luc University Clinic and Clinical and Experimental Research Institute (Pole MIRO), Catholic University of Louvain, Brussels, Belgium., Wirth L; Department of Hematology/Oncology, Massachusetts General Hospital, Boston, Massachusetts., Specenier P; Department of Medical Oncology, Antwerp University Hospital, Edegem, Belgium., Seiwert TY; Department of Hematology/Oncology, University of Chicago Medical Center, Chicago, Illinois., Mardjuadi F; King Albert II Institute, Medical Oncology Service, Saint-Luc University Clinic and Clinical and Experimental Research Institute (Pole MIRO), Catholic University of Louvain, Brussels, Belgium., Wang X; Genentech, South San Francisco, California., Kapp AV; Genentech, South San Francisco, California., Royer-Joo S; Genentech, South San Francisco, California., Penuel E; Genentech, South San Francisco, California., McCall B; Genentech, South San Francisco, California., Pirzkall A; Genentech, South San Francisco, California., Clement PM; Department of General Medical Oncology, University Hospitals Leuven, Leuven, Belgium.; Department of Oncology, KU Leuven, Leuven, Belgium.
Publikováno v:
Cancer [Cancer] 2016 Dec 15; Vol. 122 (24), pp. 3803-3811. Date of Electronic Publication: 2016 Aug 15.
Autor:
Fayette J; Centre Léon Bérard, Université de Lyon , Lyon , France., Wirth L; Massachusetts General Hospital , Boston, MA , USA., Oprean C; Oncomed SRL , Timisoara , Romania., Udrea A; Medisprof SRL , Cluj-Napoca , Romania., Jimeno A; University of Colorado Cancer Center , Aurora, CO , USA., Rischin D; Peter MacCallum Cancer Centre, University of Melbourne , Melbourne, VIC , Australia., Nutting C; Royal Marsden NHS Trust, The Institute of Cancer Research London , Sutton , UK., Harari PM; University of Wisconsin Hospital and Clinics , Madison, WI , USA., Csoszi T; Jász-Nagykun-Szolnok Megyei Hetényi Géza Kórház , Szolnok , Hungary., Cernea D; Institutul Oncologic Prof. Dr. Ion Chiricuta Cluj-Napoca , Cluj-Napoca , Romania., O'Brien P; Medical University of South Carolina , Charleston, SC , USA., Hanley WD; Genentech , South San Francisco, CA , USA., Kapp AV; Genentech , South San Francisco, CA , USA., Anderson M; Genentech , South San Francisco, CA , USA., Penuel E; Genentech , South San Francisco, CA , USA., McCall B; Genentech , South San Francisco, CA , USA., Pirzkall A; Genentech , South San Francisco, CA , USA., Vermorken JB; Antwerp University Hospital , Edegem , Belgium.
Publikováno v:
Frontiers in oncology [Front Oncol] 2016 Oct 31; Vol. 6, pp. 232. Date of Electronic Publication: 2016 Oct 31 (Print Publication: 2016).
Autor:
Cheah CY; Department of Haematology, Peter MacCallum Cancer Centre, East Melbourne, VIC, Australia; Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Melbourne, VIC, Australia; Department of Lymphoma and Myeloma, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Belada D; Fourth Department of Internal Medicine-Hematology, University Hospital and Faculty of Medicine, Hradec Kralove, Czech Republic., Fanale MA; Department of Lymphoma and Myeloma, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Janikova A; Department of Hematology and Oncology, University Hospital Brno, Brno, Czech Republic; Masaryk University Faculty of Medicine Brno, Brno, Czech Republic., Czucman MS; Roswell Park Cancer Institute, Buffalo Park, NY, USA., Flinn IW; Sarah Cannon Research Institute, Tennessee Oncology, Nashville, TN, USA., Kapp AV; Genentech, South San Francisco, CA, USA., Ashkenazi A; Genentech, South San Francisco, CA, USA., Kelley S; Genentech, South San Francisco, CA, USA., Bray GL; Genentech, South San Francisco, CA, USA., Holden S; Genentech, South San Francisco, CA, USA., Seymour JF; Department of Haematology, Peter MacCallum Cancer Centre, East Melbourne, VIC, Australia; Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Melbourne, VIC, Australia. Electronic address: john.seymour@petermac.org.
Publikováno v:
The Lancet. Haematology [Lancet Haematol] 2015 Apr; Vol. 2 (4), pp. e166-74. Date of Electronic Publication: 2015 Mar 25.
Autor:
Wainberg ZA; David Geffen School of Medicine, University of California, Los Angeles, CA. Electronic address: zwainberg@mednet.ucla.edu., Messersmith WA, Peddi PF, Kapp AV, Ashkenazi A, Royer-Joo S, Portera CC, Kozloff MF
Publikováno v:
Clinical colorectal cancer [Clin Colorectal Cancer] 2013 Dec; Vol. 12 (4), pp. 248-54. Date of Electronic Publication: 2013 Sep 27.
Autor:
Gratzinger D; Department of Pathology, Stanford University, Stanford, California, Stanford, CA 94305-5324, USA. ditag@stanford.edu, Zhao S, Marinelli RJ, Kapp AV, Tibshirani RJ, Hammer AS, Hamilton-Dutoit S, Natkunam Y
Publikováno v:
The American journal of pathology [Am J Pathol] 2007 Apr; Vol. 170 (4), pp. 1362-9.